Is There a Role for MRI-Guided Focused Ultrasound Lesioning for PD?

  • Carter S. Gerard
  • Ryder GwinnEmail author


Ultrasound has been used diagnostically in medicine for decades, but the advent of multiple phased array ultrasound transducers and MRI thermography has allowed precise transcranial application of therapeutic ultrasound energy. Stereotactic ablations can now be made in the brain without making incisions or disrupting the skull in any way. These lesions can be made in awake patients while monitoring for clinical improvement and side effects with real-time thermal mapping of the evolving ablation. This technology has been validated and approved by the FDA in the treatment of Essential Tremor, and is now undergoing evaluation for the treatment of Parkinson’s disease and several other chronic neurologic disorders. This chapter reviews the history of therapeutic ultrasound technology, the medical evidence for its efficacy in treating central nervous system disorders including Parkinson’s disease, and its future therapeutic applications.


Focused Ultrasound MRgFUS MRI-guided focused ultrasound Parkinson’s disease HIFU Sonication ExAblate 4000 


  1. 1.
    Jagannathan J, Sanghvi NT, Crum LA, Yen C-P, Medel R, Dumont AS, et al. High-intensity focused ultrasound surgery of the brain: part 1--A historical perspective with modern applications. Neurosurgery. 2009;64:201–10.; discussion 210–211.CrossRefGoogle Scholar
  2. 2.
    Christian E, Yu C, Apuzzo MLJ. Focused ultrasound: relevant history and prospects for the addition of mechanical energy to the neurosurgical armamentarium. World Neurosurg. 2014;82:354–65.CrossRefGoogle Scholar
  3. 3.
    Krishnamoorthy VK, Sengupta PP, Gentile F, Khandheria BK. History of echocardiography and its future applications in medicine. Crit Care Med. 2007;35:S309–13.CrossRefGoogle Scholar
  4. 4.
    Dobrakowski PP, Machowska-Majchrzak AK, Labuz-Roszak B, Majchrzak KG, Kluczewska E, Pierzchała KB. MR-guided focused ultrasound: a new generation treatment of Parkinson’s disease, essential tremor and neuropathic pain. Interv Neuroradiol J Peritherapeutic Neuroradiol Surg Proced Relat Neurosci. 2014;20:275–82.Google Scholar
  5. 5.
    Fry FJ, Ades HW, Fry WJ. Production of reversible changes in the central nervous system by ultrasound. Science. 1958;127:83–4.CrossRefGoogle Scholar
  6. 6.
    Jeanmonod D, Werner B, Morel A, Michels L, Zadicario E, Schiff G, et al. Transcranial magnetic resonance imaging–guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain. Neurosurg Focus. 2012;32:E1.CrossRefGoogle Scholar
  7. 7.
    Meyers R, Fry WJ, Fry FJ, Dreyer LL, Schultz DF, Noyes RF. Early experiences with ultrasonic irradiation of the pallidofugal and nigral complexes in hyperkinetic and hypertonic disorders. J Neurosurg. 1959;16:32–54.CrossRefGoogle Scholar
  8. 8.
    Clement GT, Hynynen K. A non-invasive method for focusing ultrasound through the human skull. Phys Med Biol. 2002;47:1219–36.CrossRefGoogle Scholar
  9. 9.
    Kuroda K. Non-invasive MR thermography using the water proton chemical shift. Int J Hyperth. 2005;21:547–60.CrossRefGoogle Scholar
  10. 10.
    Jung HH, Kim SJ, Roh D, Chang JG, Chang WS, Kweon EJ, et al. Bilateral thermal capsulotomy with MR-guided focused ultrasound for patients with treatment-refractory obsessive-compulsive disorder: a proof-of-concept study. Mol Psychiatry. 2015;20:1205–11.CrossRefGoogle Scholar
  11. 11.
    Elias WJ, Huss D, Voss T, Loomba J, Khaled M, Zadicario E, et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med. 2013;369:640–8.CrossRefGoogle Scholar
  12. 12.
    Elias WJ, Lipsman N, Ondo WG, Ghanouni P, Kim YG, Lee W, et al. A randomized trial of focused ultrasound thalamotomy for essential tremor. N Engl J Med. 2016;375:730–9.CrossRefGoogle Scholar
  13. 13.
    Giugno A, Maugeri R, Graziano F, Gagliardo C, Franzini A, Catalano C, et al. Restoring neurological physiology: the innovative role of high-energy MR-guided focused ultrasound (HIMRgFUS). Preliminary data from a new method of lesioning surgery. Acta Neurochir Suppl. 2017;124:55–9.CrossRefGoogle Scholar
  14. 14.
    Weintraub D, Elias WJ. The emerging role of transcranial magnetic resonance imaging-guided focused ultrasound in functional neurosurgery. Mov Disord. 2017;32(1):20–7.CrossRefGoogle Scholar
  15. 15.
    Bond AE, Dallapiazza R, Huss D, Warren AL, Sperling S, Gwinn R, et al. A randomized, sham-controlled trial of transcranial magnetic resonance-guided focused ultrasound thalamotomy trial for the treatment of tremor-dominant, idiopathic Parkinson disease. Neurosurgery. 2016;63(Suppl 1):154.CrossRefGoogle Scholar
  16. 16.
    Magara A, Bühler R, Moser D, Kowalski M, Pourtehrani P, Jeanmonod D. First experience with MR-guided focused ultrasound in the treatment of Parkinson’s disease. J Ther Ultrasound. 2014;2:11.CrossRefGoogle Scholar
  17. 17.
    Schlesinger I, Eran A, Sinai A, Erikh I, Nassar M, Goldsher D, et al. MRI guided focused ultrasound thalamotomy for moderate-to-severe tremor in Parkinson’s disease. Park Dis. 2015;2015:219149.Google Scholar
  18. 18.
    Ghanouni P, Pauly KB, Elias WJ, Henderson J, Sheehan J, Monteith S, et al. Transcranial MRI-guided focused ultrasound: a review of the technologic and neurologic applications. AJR Am J Roentgenol. 2015;205:150–9.CrossRefGoogle Scholar
  19. 19.
    Chang WS, Jung HH, Zadicario E, Rachmilevitch I, Tlusty T, Vitek S, et al. Factors associated with successful magnetic resonance-guided focused ultrasound treatment: efficiency of acoustic energy delivery through the skull. J Neurosurg. 2016;124:411–6.CrossRefGoogle Scholar
  20. 20.
    Xu Z, Carlson C, Snell J, Eames M, Hananel A, Lopes MB, et al. Intracranial inertial cavitation threshold and thermal ablation lesion creation using MRI-guided 220-kHz focused ultrasound surgery: preclinical investigation. J Neurosurg. 2015;122:152–61.CrossRefGoogle Scholar
  21. 21.
    Alkhani A, Lozano AM. Pallidotomy for parkinson disease: a review of contemporary literature. J Neurosurg. 2001;94:43–9.CrossRefGoogle Scholar
  22. 22.
    Okun MS, Vitek JL. Lesion therapy for Parkinson’s disease and other movement disorders: update and controversies. Mov Disord. 2004;19:375–89.CrossRefGoogle Scholar
  23. 23.
    Na YC, Chang WS, Jung HH, Kweon EJ, Chang JW. Unilateral magnetic resonance–guided focused ultrasound pallidotomy for Parkinson disease. Neurology. 2015;85:549–51.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of NeurosurgerySwedish Neuroscience InstituteSeattleUSA

Personalised recommendations